101 – 150 of 456
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality
(
- Contribution to journal › Article
- 2014
-
Mark
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
Prostate cancer mortality in areas with high and low prostate cancer incidence.
(
- Contribution to journal › Article
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
Cancer-associated Changes in the Expression of TMPRSS2-ERG, PCA3, and SPINK1 in Histologically Benign Tissue From Cancerous vs Noncancerous Prostatectomy Specimens.
(
- Contribution to journal › Article
-
Mark
Prevention and early detection of prostate cancer.
(
- Contribution to journal › Scientific review
-
Mark
Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Genetic Variation in KLK2 and KLK3 Is Associated with Concentrations of hK2 and PSA in Serum and Seminal Plasma in Young Men
(
- Contribution to journal › Article
-
Mark
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
(
- Contribution to journal › Article
-
Mark
MALDI-target integrated platform for affinity-captured protein digestion.
(
- Contribution to journal › Article
-
Mark
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.
(
- Contribution to journal › Article
-
Mark
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening : Population based cohort study
(
- Contribution to journal › Article
-
Mark
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
2014) In European Urology(
- Contribution to journal › Article
-
Mark
Acoustophoresis for label-free separation and concentration of cancer cells
2014) 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 In 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 p.2508-2509(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Improved acoustophoretic circulating tumor cell (CTC) separation for low target cell numbers in clinical volumes
2014) 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 In 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 p.594-596(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Aminopeptidase activities as prospective urinary biomarkers for bladder cancer
(
- Contribution to journal › Article
-
Mark
Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
(
- Contribution to journal › Article
-
Mark
Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts : Results from the prostate biopsy collaborative group
(
- Contribution to journal › Article
-
Mark
Emerging PSA-based tests to improve screening
(
- Contribution to journal › Scientific review
-
Mark
It Ain't what you do, it's the way you do it : Five golden rules for transforming prostate-specific antigen screening
(
- Contribution to journal › Article
- 2013
-
Mark
Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor Cells.
(
- Contribution to journal › Article
-
Mark
Improved porous silicon microarray based prostate specific antigen immunoassay by optimized surface density of the capture antibody
(
- Contribution to journal › Article
-
Mark
Copy number variants in the kallikrein gene cluster.
(
- Contribution to journal › Article
-
Mark
Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam
(
- Contribution to journal › Article
-
Mark
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with Percentage of Circulating Free PSA
(
- Contribution to journal › Article
-
Mark
Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort
(
- Contribution to journal › Article
-
Mark
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?
(
- Contribution to journal › Article
-
Mark
Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.
(
- Contribution to journal › Article
-
Mark
Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring.
(
- Contribution to journal › Article
-
Mark
Integrated acoustic immunoaffinity-capture (IAI) platform for detection of PSA from whole blood samples.
(
- Contribution to journal › Article
-
Mark
Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens
(
- Contribution to journal › Article
-
Mark
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
(
- Contribution to journal › Article
-
Mark
Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection
(
- Contribution to journal › Scientific review
-
Mark
Suitability of quality control materials for prostate-specific antigen (PSA) measurement : Inter-method variability of common tumor marker control materials
(
- Contribution to journal › Article
-
Mark
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men : The PROBASE trial
(
- Contribution to journal › Article
- 2012
-
Mark
PSA is Dead, Long Live PSA
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Levels of Beta-Microseminoprotein in Blood and Risk of Prostate Cancer in Multiple Populations.
2012) In Journal of the National Cancer Institute(
- Contribution to journal › Article
-
Mark
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
(
- Contribution to journal › Article
-
Mark
Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
(
- Contribution to journal › Article
-
Mark
Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function
(
- Contribution to journal › Article
-
Mark
Screening for Prostate Cancer: Early Detection or Overdetection?
(
- Contribution to journal › Scientific review
-
Mark
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
(
- Contribution to journal › Article
-
Mark
Porous silicon antibody microarrays for quantitative analysis: Measurement of free and total PSA in clinical plasma samples.
2012) In Clinica Chimica Acta(
- Contribution to journal › Article
-
Mark
Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.
(
- Contribution to journal › Article
-
Mark
Prostate-Cancer Mortality at 11 Years of Follow-up
(
- Contribution to journal › Article
-
Mark
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
(
- Contribution to journal › Article
-
Mark
Microfluidic, Label-Free Enrichment of Prostate Cancer Cells in Blood Based on Acoustophoresis
(
- Contribution to journal › Article
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article